T. Rowe Price Associates
MBII

T. Rowe Price Associates’s Marrone Bio Innovations, Inc. MBII Stock Holding History

T. Rowe Price Associates’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,300
Closed -$17K – 3012
2021
Q2 		$17K Buy
+10,300
New +$17.2K ﹤0.01% 2916

Other funds holding MBII

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates's MBII Position: Q3 2021 in Review

T. Rowe Price Associates sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2021, closing a stake of 10,300 shares — an estimated $17K sold.

T. Rowe Price Associates first reported a position in MBII in Q2 2021 and held it in 1 quarter. The position peaked at $17K in Q2 2021. 73 funds tracked by Wall St. Rank hold MBII as of Q3 2021.

  • T. Rowe Price Associates reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2021 after selling out during the quarter.
  • T. Rowe Price Associates sold 10,300 Marrone Bio Innovations, Inc. shares in Q3 2021, an estimated $17K.
  • T. Rowe Price Associates first reported a position in Marrone Bio Innovations, Inc. in Q2 2021 and held it in 1 quarter.
  • T. Rowe Price Associates's Marrone Bio Innovations, Inc. position peaked at $17K in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2021.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.